(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -46.41%5.06B | -20.69%32.81B | -6.99%25.68B | 26.47%18.11B | 75.91%9.44B | 274.63%41.37B | 291.45%27.61B | 255.80%14.32B | 233.91%5.37B | 101.20%11.04B |
Operating income | -46.41%5.06B | -20.69%32.81B | -6.99%25.68B | 26.47%18.11B | 75.91%9.44B | 274.63%41.37B | 291.45%27.61B | 255.80%14.32B | 233.91%5.37B | 101.20%11.04B |
Cost of sales | ---- | -34.26%-28.2B | ---- | -146.90%-13.98B | ---- | -214.18%-21.01B | ---- | -116.17%-5.66B | ---- | -54.52%-6.69B |
Operating expenses | 19.78%-4.74B | -34.26%-28.2B | -74.24%-21.21B | -146.90%-13.98B | -230.59%-5.92B | -214.18%-21.01B | -167.74%-12.17B | -116.17%-5.66B | -61.64%-1.79B | -54.52%-6.69B |
Gross profit | -91.12%313.03M | -77.37%4.61B | -71.03%4.47B | -52.30%4.13B | -1.48%3.52B | 367.39%20.36B | 515.75%15.44B | 516.08%8.66B | 615.33%3.58B | 275.08%4.36B |
Selling expenses | -42.02%-42.49M | -51.19%-177.44M | -46.13%-102.14M | -69.27%-68.73M | -158.47%-29.92M | -90.45%-117.36M | -84.60%-69.89M | -69.74%-40.6M | 8.23%-11.57M | -27.82%-61.62M |
Administrative expenses | -102.27%-304.85M | -16.78%-2.34B | -28.31%-654.98M | -16.51%-1.06B | 31.23%-150.72M | -137.96%-2B | -79.88%-510.48M | -332.53%-912.27M | -577.20%-219.16M | -155.94%-840.34M |
Research and development expenses | 44.67%-216.84M | ---- | 1.13%-941.62M | ---- | -84.99%-391.93M | ---- | -373.80%-952.43M | ---- | -477.87%-211.86M | ---- |
Profit from asset sales | -81.59%-24.67K | ---- | -65.30%1.39M | ---- | ---13.59K | ---- | 1,776.76%3.99M | ---- | ---- | ---- |
Revaluation surplus | -274.78%-268.86M | ---- | 24.76%650.52M | ---- | -67.56%153.83M | ---- | -47.53%521.44M | ---- | 187.17%474.21M | ---- |
-Changes in the fair value of other assets | -274.78%-268.86M | ---- | 24.76%650.52M | ---- | -67.56%153.83M | ---- | -47.53%521.44M | ---- | 187.17%474.21M | ---- |
Impairment and provision | 91.88%-97.62M | ---- | -2,471.08%-1.01B | ---- | -1,222,994.39%-1.2B | ---- | -221.98%-39.29M | ---- | -22.79%-98.32K | ---- |
-Other impairment is provision | 91.88%-97.62M | ---- | -2,471.08%-1.01B | ---- | -1,222,994.39%-1.2B | ---- | -221.98%-39.29M | ---- | -22.79%-98.32K | ---- |
Operating interest expense | ---- | ---- | ---- | -75.95%-342.58M | ---- | ---- | ---- | -36.24%-194.71M | ---- | 0.39%-264.86M |
Special items of operating profit | -42.92%345.73M | 2.80%1.05B | 47.26%4.31B | 318.50%1.36B | 29.45%605.69M | -59.32%1.02B | 5,744.98%2.93B | -197.39%-620.54M | 3,340.25%467.89M | 319.46%2.52B |
Operating profit | -111.65%-290.34M | -83.66%3.15B | -61.01%6.67B | -41.78%4.01B | -38.31%2.49B | 237.56%19.27B | 475.71%17.11B | 313.87%6.89B | 591.53%4.04B | 409.87%5.71B |
Financing cost | -50.48%-209.41M | -92.55%-784.31M | -477.51%-379.61M | ---- | -251.25%-139.16M | ---407.33M | 167.67%100.56M | ---- | 23.43%-39.62M | ---- |
Share of profits of associates | ---- | -44.83%923.76M | ---- | 0.30%620.29M | ---- | 2,401.34%1.67B | ---- | 1,582.72%618.43M | ---- | 364.55%66.94M |
Share of profit from joint venture company | ---- | -10.47%2.01B | ---- | 78.07%1.62B | ---- | 42,985.18%2.24B | ---- | 1,536.91%909.21M | ---- | -115.61%-5.22M |
Special items of earning before tax | 83.37%-35.12K | ---- | 78.19%44.6M | ---- | -100.66%-211.19K | ---- | 451.86%25.03M | ---- | 98,424.68%31.87M | ---- |
Earning before tax | -121.23%-499.78M | -76.76%5.29B | -63.24%6.34B | -25.74%6.25B | -41.64%2.35B | 294.71%22.78B | 512.00%17.23B | 413.83%8.42B | 657.30%4.03B | 411.65%5.77B |
Tax | 49.48%-95.87M | 70.52%-683.47M | 79.70%-455.97M | 64.57%-377.64M | 59.91%-189.78M | -549.34%-2.32B | -718.81%-2.25B | -502.34%-1.07B | -1,115.48%-473.42M | -460.54%-357M |
After-tax profit from continuing operations | -127.53%-595.65M | -77.46%4.61B | -60.77%5.88B | -20.11%5.87B | -39.21%2.16B | 277.92%20.46B | 489.68%14.99B | 403.11%7.35B | 621.15%3.56B | 408.73%5.41B |
Earning after tax | -127.53%-595.65M | -77.46%4.61B | -60.77%5.88B | -20.11%5.87B | -39.21%2.16B | 277.92%20.46B | 489.68%14.99B | 403.11%7.35B | 621.15%3.56B | 408.73%5.41B |
Minority profit | 32.62%-156.75M | -765.08%-371.56M | -167.78%-130.35M | -103.55%-3.43M | -765.72%-232.63M | -122.83%-42.95M | 179.56%192.32M | 110.08%96.74M | 98.93%34.94M | 383.36%188.14M |
Profit attributable to shareholders | -118.31%-438.9M | -75.70%4.98B | -59.38%6.01B | -19.00%5.88B | -32.01%2.4B | 292.35%20.5B | 498.31%14.79B | 412.65%7.25B | 640.41%3.53B | 409.69%5.23B |
Basic earnings per share | -118.49%-0.22 | -75.74%2.47 | -59.46%2.98 | -18.89%2.92 | -32.00%1.19 | 281.27%10.18 | 315.25%7.35 | 386.49%3.6 | 386.11%1.75 | 237.97%2.67 |
Diluted earnings per share | -118.49%-0.22 | -75.71%2.47 | -59.35%2.98 | -18.89%2.92 | -32.00%1.19 | 282.33%10.17 | 314.12%7.33 | 386.49%3.6 | 386.11%1.75 | 236.71%2.66 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data